A 5 month-old Amish male infant with CGD underwent BMT from his 5 year-old, histocompatible brother after a preconditioning regimen of busulfan 8 mg/kg and cyclophosphamide 200 mglkg. At the time of BMT, he was free of infection and remained so through the course of his transplant. He engrafted promptly with complete reversal of the neutrophil function defect (Table) , and no sign of graft vs. host disease. This was followed by loss of the erythroid graft and gradual deterioration in neutrophil function (Table) . Now, 16 months after BMT, he is free of infection, growing normally with essentially no evidence for neutrophil engraftment. We studied the interaction of Pb and Fe on ferrochelatacf. r?e mitochondria1 enzvme that catalyzes the incorcorat'on sf Fe into Drotoooronvrin. Mitochondria were Isolated from rer?cu'ocvtes of oatients with sickle-ce?i svndromes underaoTna tncraoeutic exchange transfusions. Enzyme rinetic5 of terrocneiatase were then studied on freeze-thawed oreoarations bv measurlrlo thi! incor~oration of 59Fe intc qeme. In the absence ot Pb. the hmfe was 13 f l M . and Vmax was .O21 pMlrnlqlmg orofein. 11 the oresence of varving concentrations of Pb. the a more marked inhibition could be 3emonstratea when the Fe concentration was below 10 pM.
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FEVER IN INFANTS AND YOUNG CHILDREN WITH SICKLE CELL

DISEASE (SCD
These data demonstrate ?hat. when Fe deficiencv 3s oresent.
human mi tocnondrial ferrochelatase is more sensitive to the eff e c~ of ion doses of Pb.
These results indicate a Dossib'e biocnemicai mechanism for the clinical interactions of ' e defiz'?*cv an3 PC ooisonina in children. Plasma Antithrombin I11 activity (AT-IIIAc) and antigen (ATIIIAgn) levels were determined in 75 children with SCD in the steady state aged 2 to 19 yrs (mean of 9.6 + 5.6) and in matched controls. Thirty-three of these patients were also studied during steady state (SS) and during vaso-occlusive crisis (VOC Central nervous system bleeding is the main cause of death in hemophilia accounting for 34% of all deaths. Between January 1981 and December 1983, 26 children with hemophilia ranging in age from 1 to 17 years (mean of 7.5 5 4.5) had 67 hospital admissions for head trauma. Eighteen had Factor VIII, seven Factor IX deficiency and one Von Willebrand's Disease. Of the 26 children, 17 had severe hemophilia and 2 had Factor VIII inhibitors. All patients had scalp hematoma; 3 had lacerations at the site of the hematoma; 1 had severe cerebral concussion; 3 had a history of possible loss of consciousness; 12 had headache; 1 had vomiting and 4 had dizziness on admission. All patients received factor replacement therapy within 12 hours of trauma and factor levels were maintained over 50% for 2 to 9 days (mean 2.7 + 1.1) and all recovered without sequelae. Eightteen patients had skull x-rays on 38 occasions, all of which were negative. Six patients had EEGs, all of which were normal. Of 20 patients who hid CT scans on 25 occasions, all were negative. Hemophilia patients treated with adequate factor replacement following head trauma have an excellent prognosis and in the absence of persistent neurological signs or symptoms probably do not require CT examination. Sixteen episodes of priapism in 6 children with SCD, aged from 9 to 15 years (mean 12.0 + 2.5) were trea~ed with 2 or 3 PET. In 14 episodes (4 patients) PET was started within 6 to 8 hours from the onset. Marked clinical improvement occurred within 1.3 2 0.5 days and complete recovery followed each episode. In 2 episodes ( 2 patients) PET was started at 17 and 20 hours from the onset. In these 2 cases there was only partial response to PET and needle aspiration of corpora cavernosm and glandular A-V fistula were performed at the 3rd and 5th day of the onset, respectivelv.
PLASMA ANTITHROMBIN 111 LEVELS IN CHILDREN IJITE HOMO-ZYGOUS SICKLE CELL DISEASE (SCD). Gun or Kara alcin,
In the steady state, AT-IIIAc was below control values whereas AT-IIIAgn levels were normal. 
